CATALENT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.95 USD | -0.14% |
|
-0.02% | +24.53% |
| Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
| Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Presenter SpeechJohn Kreger (Analysts)Everyone. We're going to get started now. Our next sessi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows:
- provision of development services and clinical supply services (55.4%);
- subcontracted manufacturing services (44.6%).
Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q3 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
55.95
USD
Average target price
63.5
USD
Spread / Average Target
+13.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.53% | 10.13B | |
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Transcript : Catalent, Inc. Presents at William Blair’s 42nd Annual Growth Stock Conference 2022, Jun-07-2022 01
